Search This Blog

Monday, August 12, 2019

BeiGene target cut to $201 from $207 by Morgan Stanley

Maintains Overweight
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)